Insulin Delivery Systems: A Global Strategic Business Report
San Jose, CA (PRWEB) March 23, 2010
Diabetes, a chronic disease with significant worldwide prevalence, results due to the inability of the pancreas to secrete appropriate levels of insulin. Diabetes patients, however, can lead a normal life, with daily, lifelong dependence on insulin injections. This makes insulin delivery systems an important part of their daily life. There are conventional as well as modern approaches to insulin delivery, comprising Insulin Syringes, Insulin Pens, External Insulin Pumps, Insulin Jet Injectors and Pen Injectors.
The United States dominates the world insulin delivery systems market as stated by the new market research report on insulin delivery systems market. The US market exhibits strong demand for insulin delivery systems, as diabetes is widely prevalent across the country. An ageing population and obesity represent the leading risk factors contributing to the growing prevalence of diabetes. Introduction of advanced formulations and administration devices will also propel the demand for insulin delivery systems. Among insulin delivery systems, the market is quite largest for insulin pumps, and relatively small, but growing for insulin pens.
Unlike the United States, the penetration of insulin pens is quite high in the European countries. Convenience and flexibility of insulin delivery provides insulin pens an edge compared to insulin syringes or even insulin pumps in this part of the world. However, the demand for insulin pumps, as well, is growing in Europe, with the Internet playing a crucial role in promoting this modern insulin delivery system.
Several companies are engaged in manufacturing insulin syringes, insulin pumps (external) and insulin pens, and a different player dominates each of these three markets, at the global level. Key players profiled in the report include Antares Pharma, Inc.; Becton, Dickinson and Company; Eli Lilly and Company; F. Hoffmann-La Roche, Ltd.; Disetronic Medical Systems, Inc.; Generex Biotechnology Corporation; Insulet Corporation; Medical Plastic Devices Inc.; Medtronic Inc.; Novo Nordisk A/S; Patton Medical Devices, LP; Sanofi-aventis; Smiths Medical MD, Inc.; and Ypsomed AG, among others.
The report titled "Insulin Delivery Systems: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, competitive scenario, research & development, product introductions, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including The United States, Europe and Rest of World. While analytics for Insulin Syringes and External Insulin Pumps segments are provided for US, Europe and Rest of World markets, Insulin Pens are analyzed for the US and European markets.
For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Insulin_Delivery_Systems_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/